Skip to main content

Table 2 Prevalence of malaria in pregnant women in antenatal care (N = 2 044)

From: Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire

   IPT-SP dose
  Total
(N = 2 044)
0
(n = 333)
1
(n = 694)
2
(n = 821)
≥3
(n = 196)
P value
Mothers       
Peripheral cord blood positive       
   Rapid Malaria test (ACON®) 21 (1.0) 6 (1.8) 8 (1.2) 6 (0.7) 1 (0.5) 0.358
   95% Confidence interval [0.64-1.57] [0.66 - 3.88] [0.50-2.26] [0.27-1.58] [0.00-2.81]  
   Blood smears 19 (0.9) 6 (1.8) 7 (1.0) 6 (0.7) 0 (0.0) 0.564
   95% Confidence interval [0.56-1.44] [0.66 - 3.88] [0.41-2.07] [0.27-1.58] [0.00-1.86]  
Placental blood positives       
   Rapid Malaria test (ACON®) 109 (5.3) 39 (11.7) 34 (4.9) 27 (3.3) 9 (4.6) < 0.001
   95% Confidence interval [4.40-6.40] [8.46-15.66] [3.42-6.78] [2.18-4.75] [2.12-8.54]  
   Blood smears 99 (4.8) 39 (11.7) 31 (4.5) 23 (2.8) 6 (3.1) 0.026
   95% Confidence interval [3.95 - 5.86] [8.46-15.66] [3.05-6.28] [1.78 - 4.17] [1.13-6.54]  
Neonates       
   Number of available specimens* 85 35 26 19 5  
   Peripheral blood positives 4 (4.7) 2 (5.7) 1 (3.8) 1 (5.3) 0 (0.0) 1.00
   95 % Confidence interval [1.30-11.61] [0.70-19.16] [0.10-19.64] [0.13-26.03] [0.00-52.18]  
  1. * From mothers with placenta blood positive
  2. ε One missing observation
  3. IQR: Interquartile range
  4. IPT-SP: Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine
  5. ITNs: insecticide-treated mosquito nets